PHS
PFM Health Sciences Portfolio holdings
AUM
$1.15B
This Quarter Return
+34.3%
1 Year Return
+21.39%
3 Year Return
+130.75%
5 Year Return
+265.32%
10 Year Return
+1,236.5%
AUM
$1.64B
AUM Growth
+$1.64B
(+35%)
Cap. Flow
+$192M
Cap. Flow
% of AUM
11.73%
Top 10 Holdings %
Top 10 Hldgs %
38.22%
Holding
89
New
20
Increased
15
Reduced
21
Closed
18
Top Buys
| 1 |
IMMU
Immunomedics Inc
IMMU
|
$75M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$63.5M |
| 3 |
Labcorp
LH
|
$51.5M |
| 4 |
Hologic
HOLX
|
$35M |
| 5 |
AstraZeneca
AZN
|
$33.6M |
Top Sells
| 1 |
Pfizer
PFE
|
$38.5M |
| 2 |
Becton Dickinson
BDX
|
$34.7M |
| 3 |
Cigna
CI
|
$34.5M |
| 4 |
Elevance Health
ELV
|
$32.6M |
| 5 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
$30.7M |
Sector Composition
| 1 | Healthcare | 78.58% |
| 2 | Technology | 5.03% |
| 3 | Consumer Discretionary | 1.56% |
| 4 | Industrials | 0.73% |
| 5 | Financials | 0.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Baxter International
BAX
$12.7B
| $25.4M | 1.32% | 295,222 -14,413 | -5% | -$1.24M |
|
27
Teva Pharmaceuticals
TEVA
$21.1B
| $25.1M | 1.3% | +2,034,296 | New | +$25.1M |
|
28
Zimmer Biomet
ZBH
$21B
| $21.5M | 1.11% | +179,891 | New | +$21.5M |
|
29
Penumbra
PEN
$10.6B
| $19.9M | 1.03% | 111,302 -6,888 | -6% | -$1.23M |
|
30
Microsoft
MSFT
$3.77T
| $19.4M | 1% | 95,177 | – | – |
|
|
MNTA
31
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $19.3M | 1% | +579,994 | New | +$19.3M |
|
|
XYZ
32
Block, Inc.
XYZ
$48.5B
| $19M | 0.99% | +181,509 | New | +$19M |
|
33
Icon
ICLR
$13.8B
| $17.3M | 0.9% | 102,966 +10,520 | +11% | +$1.77M |
|
34
Vertex Pharmaceuticals
VRTX
$100B
| $17.1M | 0.89% | 59,035 -36,447 | -38% | -$10.6M |
|
35
Molina Healthcare
MOH
$9.8B
| $16.6M | 0.86% | 93,168 -31,276 | -25% | -$5.57M |
|
36
UnitedHealth
UNH
$281B
| $16.5M | 0.86% | 55,910 -48,812 | -47% | -$14.4M |
|
|
ARNA
37
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $16.5M | 0.85% | 261,808 -487,409 | -65% | -$30.7M |
|
38
Halozyme
HALO
$8.56B
| $16M | 0.83% | 597,545 -21,181 | -3% | -$568K |
|
|
DCPH
39
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $14.9M | 0.77% | 250,133 +43,797 | +21% | +$2.62M |
|
40
Amazon
AMZN
$2.44T
| $14.7M | 0.76% | 5,342 | – | – |
|
41
NXP Semiconductors
NXPI
$59.2B
| $14.6M | 0.76% | +127,871 | New | +$14.6M |
|
42
NVIDIA
NVDA
$4.24T
| $14.5M | 0.75% | 38,113 -23,729 | -38% | -$9.02M |
|
43
Exact Sciences
EXAS
$8.98B
| $14.1M | 0.73% | +161,679 | New | +$14.1M |
|
|
NVRO
44
DELISTED
NEVRO CORP.
NVRO
| $12.4M | 0.65% | +104,180 | New | +$12.4M |
|
45
Deere & Co
DE
$129B
| $12M | 0.62% | 76,336 +36,128 | +90% | +$5.68M |
|
46
Johnson & Johnson
JNJ
$427B
| $10.9M | 0.56% | 77,167 -89,208 | -54% | -$12.5M |
|
47
Aptiv
APTV
$17.3B
| $10.7M | 0.56% | +137,757 | New | +$10.7M |
|
48
Tenet Healthcare
THC
$16.3B
| $10.5M | 0.54% | +578,625 | New | +$10.5M |
|
49
Dynavax Technologies
DVAX
$1.19B
| $10.1M | 0.53% | +1,143,526 | New | +$10.1M |
|
50
Quest Diagnostics
DGX
$20.3B
| $10.1M | 0.53% | +88,933 | New | +$10.1M |
|